Homma Midori, Miura Misa, Hirayama Yo, Takahashi Tamao, Miura Takahiro, Yoshida Naoki, Miyata Satoshi, Kohzuki Masahiro, Ebihara Satoru
Department of Internal Medicine & Rehabilitation Science, Disability Sciences, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai 980-8574, Japan.
Hirayama Hospital, Hanamigawa 1494-3, Hanamigawa-ku, Chiba 262-0046, Japan.
J Clin Med. 2022 Oct 19;11(20):6170. doi: 10.3390/jcm11206170.
Background: Although patients receiving hemodialysis are more likely to develop metabolic disorders and muscle weakness at an earlier stage than healthy individuals, many older dialysis patients have difficulty establishing exercise habits to prevent these problems. Therefore, we evaluated the use of belt electrode-skeletal muscle electrical stimulation (B-SES), which can stimulate a wider area than conventional electrical muscle stimulation (EMS), to examine its application and safety in older hemodialysis patients as a means to improve lower extremity function without voluntary effort. Methods: This study was a randomized controlled trial (RCT) involving 20 older dialysis patients (>65 years old) with reduced physical activity. The control group received 12 weeks of routine care only and the intervention group received 12 weeks of B-SES during hemodialysis in addition to routine care. The primary endpoint was the 6 min walk test (6MWT) distance, while the Short Physical Performance Battery (SPPB), body composition, Functional Independence Measure (FIM), biochemistry test, and blood pressure/pulse measurements were used as secondary endpoints. Results: As a result of the 12-week B-SES intervention, no increase in creatine kinase or C-reactive protein levels was observed after the intervention in either group, and no adverse events attributed to the B-SES intervention were observed in the intervention group. Furthermore, the intervention group showed a significant improvement in the 6MWT and SPPB scores after the intervention. Conclusions: The results of this study suggest that a 12-week B-SES intervention during hemodialysis sessions safely improves 6MWT distance and SPPB scores in older patients with a reduced level of physical activity.
尽管接受血液透析的患者比健康个体更早出现代谢紊乱和肌肉无力,但许多老年透析患者难以养成预防这些问题的运动习惯。因此,我们评估了带状电极-骨骼肌电刺激(B-SES)的应用,它比传统的肌肉电刺激(EMS)能刺激更大的区域,以研究其在老年血液透析患者中的应用及安全性,作为一种无需自主努力即可改善下肢功能的方法。方法:本研究为一项随机对照试验(RCT),纳入20名身体活动减少的老年透析患者(>65岁)。对照组仅接受12周的常规护理,干预组在常规护理基础上,在血液透析期间接受12周的B-SES治疗。主要终点为6分钟步行试验(6MWT)距离,次要终点包括简短体能状况量表(SPPB)、身体成分、功能独立性测量(FIM)、生化检查以及血压/脉搏测量。结果:经过12周的B-SES干预,两组干预后肌酸激酶或C反应蛋白水平均未升高,干预组未观察到归因于B-SES干预的不良事件。此外,干预组干预后6MWT和SPPB评分有显著改善。结论:本研究结果表明,在血液透析期间进行12周的B-SES干预可安全地改善身体活动水平降低的老年患者的6MWT距离和SPPB评分。